Gene-mapper raises $100m from venture heavyweights

Pacific Biosciences has lured the backing of an eclectic consortium of investors including Kleiner Perkins, Ontario Teachers’ and fixed income hedge fund Deerfield.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this